They stimulate the pancreas to release more insulin when blood sugar is high and suppress the release of glucagon, a hormone that raises blood sugar
In research protocols, this can be either desirable (for models examining appetite regulation, weight gain, or catabolic disease states) or undesirable (for protocols where appetite stimulation is a confounder)
Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that has generated questions about potential effects on sexual function
I can go on and on about watching Vioxx, Accutane, Fen Phen, Baycal, Bextra, Premarin, Prempro, Zantac/Ranitidine, come and go but we will focus on semaglutide today
The cold dissolving is slower but gentler
Commercial health plans have in place prior authorization requirements to try to limit coverage of new weight-loss shots to those who qualify for these treatments